KRYS

Krystal Biotech (KRYS)

Krystal Biotech Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KRYS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/13	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/09/06	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/08/29	05 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/08/28	20 : 00	GlobeNewswire Inc.	Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté	NASDAQ:KRYS	Krystal Biotech Inc
2024/08/05	21 : 08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KRYS	Krystal Biotech Inc
2024/08/05	21 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/08/05	21 : 00	GlobeNewswire Inc.	Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates	NASDAQ:KRYS	Krystal Biotech Inc
2024/08/05	18 : 46	IH Market News	U.S. Index Futures and Oil Prices Plunge on Recession Concerns	NASDAQ:KRYS	Krystal Biotech Inc
2024/07/26	21 : 00	GlobeNewswire Inc.	Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024	NASDAQ:KRYS	Krystal Biotech Inc
2024/06/08	07 : 09	PR Newswire (US)	KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600	NASDAQ:KRYS	Krystal Biotech Inc
2024/06/05	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/22	05 : 38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/15	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at the American Thoracic Society 2024 International Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/08	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at BofA Securities 2024 Health Care Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21 : 17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21 : 09	IH Market News	Index Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices Rise	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21 : 00	GlobeNewswire Inc.	Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/02	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting	NASDAQ:KRYS	Krystal Biotech Inc
2024/04/26	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024	NASDAQ:KRYS	Krystal Biotech Inc
2024/04/22	20 : 00	GlobeNewswire Inc.	Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung	NASDAQ:KRYS	Krystal Biotech Inc
2024/04/04	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	NASDAQ:KRYS	Krystal Biotech Inc
2024/03/02	10 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/03/02	10 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/29	11 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/28	21 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/27	03 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	22 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	22 : 00	GlobeNewswire Inc.	Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	21 : 59	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:KRYS	Krystal Biotech Inc